Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Raises Vioxx, Arcoxia Guidance; Ex-U.S. Sales Spur Growth

Jul 26 2004

• By The Pink Sheet

Related Content

Merck Sees Strong Cholesterol Market In ‘04; Zocor Growth, Profit From Zetia

Dec 08 2003

Zocor Sales To Take $500 Mil. Hit In 2003 From Merck Inventory Program

Oct 27 2003

Merck Arcoxia 6,000-Patient Trial Will Study GI, Cardiac Events

Jun 17 2002

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window